Inhibiteurs de la DGAT

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

申请号：

EP11158220.1

公开号：

EP2402318A1

申请日:

2007.03.28

申请国别(地区):

EP

年份:

2012

代理人:

摘要：

The present invention provides new organic compounds of the following formula:wherein A, L1, B, L2 and E are as defined in the description of the invention, that are useful for treating conditions or disorders associated with DGAT1 activity, particularly type 2 diabetes, and pharmaceutical compositions and combinations comprising such compounds.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/